Published in Cochrane Database Syst Rev on January 01, 2000
Reduce Risk for Crohn's Disease Patients (RCT) | NCT02852694
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut (2005) 2.33
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11
Treatment of inflammatory bowel disease: a review of medical therapy. World J Gastroenterol (2008) 1.52
Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance. Dig Dis Sci (2014) 1.41
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol (2012) 1.40
Retracted Biologic targeting in the treatment of inflammatory bowel diseases. Biologics (2009) 1.20
Inflammatory bowel disease. Arch Dis Child (2006) 1.00
Anti-TNF strategies in stenosing and fistulizing Crohn's disease. Int J Colorectal Dis (2004) 0.98
Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol (2008) 0.96
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients. Dig Dis Sci (2006) 0.92
Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol (2007) 0.91
Response to Magro et al. Am J Gastroenterol (2015) 0.91
Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients. World J Surg (2009) 0.90
Pharmacogenetics in inflammatory bowel disease. World J Gastroenterol (2006) 0.90
Postoperative Crohn's disease recurrence: a practical approach. World J Gastroenterol (2008) 0.88
Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig Dis Sci (2007) 0.86
Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol (2014) 0.84
Outcome of patients with nonstenotic, nonfistulizing Crohn's disease. Dig Dis Sci (2005) 0.84
Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease. World J Gastroenterol (2011) 0.83
Conventional therapy for Crohn's disease. World J Gastroenterol (2006) 0.82
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World J Gastroenterol (2011) 0.82
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2008) 0.80
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal. Gastroenterol Res Pract (2015) 0.79
Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine Therapy. Mol Diagn Ther (2016) 0.79
Role of conventional therapies in the era of biological treatment in Crohn's disease. World J Gastroenterol (2011) 0.78
Routine use of thiopurines in maintaining remission in pediatric Crohn's disease. World J Gastroenterol (2014) 0.77
Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease. Dig Dis Sci (2011) 0.77
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). Int J Nanomedicine (2007) 0.77
Management of Perianal Crohn's Disease. Curr Treat Options Gastroenterol (2005) 0.77
What is the impact of age on adult patients with inflammatory bowel disease? Clujul Med (2013) 0.77
Practical medical management of Crohn's disease. ISRN Gastroenterol (2013) 0.77
Medical Therapy of Crohn's Disease. Curr Treat Options Gastroenterol (2005) 0.76
AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings. PLoS Negl Trop Dis (2017) 0.75
A rolling phenotype in Crohn's disease. PLoS One (2017) 0.75
Postoperative Effects of Thiopurines in Patients with Intestinal Behçet's Disease. Dig Dis Sci (2015) 0.75
Are we giving azathioprine too much time? World J Gastroenterol (2008) 0.75
Crohn's disease: we are in it for the long haul. Interview by Paul C Adams. Can J Gastroenterol (2008) 0.75
Standards of medical treatment and nutrition in Crohn's disease. Langenbecks Arch Surg (2004) 0.75
The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease. Ther Adv Chronic Dis (2010) 0.75
Monitoring thiopurine metabolites in inflammatory bowel disease. Frontline Gastroenterol (2016) 0.75
Adherence to an elemental diet for preventing postoperative recurrence of Crohn's disease. Surg Today (2017) 0.75
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med (1995) 2.95
Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology (1991) 2.93
Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology (1993) 2.75
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut (2000) 2.67
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. N Engl J Med (1994) 2.52
Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology (1993) 2.46
Percutaneous removal of kidney stones: review of 1,000 cases. J Urol (1985) 2.04
Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med (1993) 2.03
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology (1990) 1.79
Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med (1989) 1.78
Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med (1998) 1.77
Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology (1992) 1.67
Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr (1990) 1.67
Alternative medicine and general practitioners. Opinions and behaviour. Can Fam Physician (1995) 1.67
Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. N Engl J Med (1985) 1.57
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Defining the role of fiberoptic sigmoidoscopy in the investigation of patients presenting with bright red rectal bleeding. Am J Gastroenterol (2000) 1.49
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology (1998) 1.48
Use of alternative medicine by patients attending a gastroenterology clinic. CMAJ (1990) 1.46
Should elective endoscopic sphincterotomy replace cholecystectomy for the treatment of high-risk patients with gallstone pancreatitis? J Clin Gastroenterol (1991) 1.43
Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology (1996) 1.31
Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology (1985) 1.31
Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology (1996) 1.29
Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest (1998) 1.27
Cholelitholysis using methyl tertiary butyl ether. Gastroenterology (1985) 1.24
Endothelium-derived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol (1988) 1.21
Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. Gastroenterology (1987) 1.20
Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology (1995) 1.16
Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol (2001) 1.13
Suicide following an inpatient hospitalization for a suicide attempt: a Canadian follow-up study. Soc Psychiatry Psychiatr Epidemiol (1998) 1.09
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease. Ital J Gastroenterol Hepatol (1998) 1.09
The effect of elastic bandages on human knee proprioception in the uninjured population. Am J Sports Med (1995) 1.07
Characterization of airborne mineral dusts associated with farming activities in rural Alberta, Canada. Int Arch Occup Environ Health (1990) 1.06
Chronic right upper quadrant pain without gallstones: does HIDA scan predict outcome after cholecystectomy? Am J Gastroenterol (1990) 1.04
Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut (1995) 1.04
General practitioners' assessment of and interest in alternative medicine in Canada. Soc Sci Med (1995) 1.04
Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there? Gastroenterology (2000) 1.02
Gastrointestinal symptoms in ambulatory HIV-infected patients. Dig Dis Sci (1993) 1.01
Percutaneous biliary decompression: internal and external drainage in 50 patients. AJR Am J Roentgenol (1981) 0.99
Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys (1984) 0.98
Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? Mayo Clin Proc (1986) 0.98
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology (1996) 0.98
A mathematical model for the glucose induced insulin release in man. Eur J Clin Invest (1974) 0.97
Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. J Appl Physiol (1985) (1989) 0.97
The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms. Am J Gastroenterol (1998) 0.96
Erratic zidovudine bioavailability in HIV seropositive patients. J Antimicrob Chemother (1993) 0.95
Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets. Br J Pharmacol (1990) 0.94
Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol (1997) 0.94
Benign postoperative biliary strictures: dilation with fluoroscopic guidance. Radiology (1987) 0.93
Review article: treatment of Clostridium difficile infection. Aliment Pharmacol Ther (1997) 0.93
Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol (1999) 0.92
The pancreas in the degu. Exp Mol Pathol (1984) 0.92
Percutaneous lithotripsy. J Urol (1983) 0.91
The chronological sequence in the pathology of Crohn's disease. J Clin Gastroenterol (1988) 0.91
Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist. Can J Gastroenterol (2001) 0.91
Intestinal permeability in patients with Crohn's disease. Gut (1994) 0.90
Preoperative staging of rectal carcinoma by computed tomography and 0.15T magnetic resonance imaging. Preliminary report. Dis Colon Rectum (1986) 0.90
Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR Am J Roentgenol (1985) 0.90
Comparison of 0.25 mg and 0.1 mg intrathecal morphine for analgesia after Cesarean section. Can J Anaesth (1999) 0.90
Effect of oral contraceptive use on reoperation following surgery for Crohn's disease. Dig Dis Sci (1992) 0.90
Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis (1999) 0.89
Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ Shock (1994) 0.89
Volume and acidity of residual gastric fluid after oral fluid ingestion before elective ambulatory surgery. CMAJ (1989) 0.89
Magnetic resonance imaging in a routine clinical setting. Mayo Clin Proc (1985) 0.87
HIV-associated non-Hodgkin's lymphoma of the gastrointestinal tract. Am J Gastroenterol (1996) 0.86
Survey of current practices among members of CAG in the follow-up of patients diagnosed with gastric ulcer. Can J Gastroenterol (1999) 0.86
Determinants of abstract acceptance for the Digestive Diseases Week--a cross sectional study. BMC Med Res Methodol (2001) 0.86
Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol (2007) 0.85
Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis (2000) 0.85
Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. The University of Calgary Gastrointestinal/HIV Study Group. AIDS (1992) 0.85
Reticuloendothelial system Fc receptor-mediated clearance of IgG-tagged erythrocytes from the circulation of patients with idiopathic ulcerative colitis and chronic liver disease. Hepatology (1986) 0.85
Fluticasone propionate for treatment of esophageal lichen planus. A case series. Dis Esophagus (2010) 0.84
Percutaneous removal of small ureteral calculi. AJR Am J Roentgenol (1985) 0.84
Bone tumors: magnetic resonance imaging versus computed tomography. Radiology (1985) 0.83
On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart. J Mol Cell Cardiol (1996) 0.83
Zidovudine absorption and small intestinal function in HIV seropositive patients. J Antimicrob Chemother (1996) 0.83
Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med (1997) 0.82
Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther (1993) 0.82
Effect of heterozygosity for the methionine synthase 2756 A-->G mutation on the risk for recurrent cardiovascular events. Am J Cardiol (2000) 0.82
Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group. J Acquir Immune Defic Syndr (1992) 0.82
Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sci (1991) 0.82
Adding fentanyl 0.0002% to epidural bupivacaine 0.125% does not delay gastric emptying in laboring parturients. Anesth Analg (1996) 0.81
Peptides in the gastrointestinal tract in human immunodeficiency virus infection. The GI/HIV Study Group of the University of Calgary. Gastroenterology (1992) 0.81
Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology (1988) 0.81
5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis. Am J Gastroenterol (1997) 0.80
Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. Radiology (1985) 0.79
Magnetic resonance imaging of osteosarcomas. Comparison with computed tomography. Clin Orthop Relat Res (1986) 0.79
Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease. Am J Kidney Dis (1996) 0.79
C1 inhibitor deficiency and angioedema of the small intestine masquerading as Crohn's disease. Can J Gastroenterol (2000) 0.79
Percutaneous nephrostomy for stone removal. Radiology (1984) 0.79
The effect of propofol on the canine sphincter of Oddi. HPB Surg (1994) 0.78
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. Aliment Pharmacol Ther (2005) 0.78
Helping patients with Crohn's disease quit smoking. Am J Gastroenterol (2000) 0.78
Ro 15-1788 and hepatic failure. Ann Intern Med (1988) 0.78